Loading organizations...
Loading organizations...
| Date | Company | Round | Lead Investor(s) | Co-Investor(s) |
|---|---|---|---|---|
| Oct 8, 2013 | Amaranth Medical | $20.0M Series B | DCP Capital | Swee Yeok CHU, PBM, Fred M. Schwarzer, Phillip Capital, Venstar Capital |
| Apr 2, 2013 | Revance Therapeutics | $104.0M Other Equity / Series E | — | Delphi Ventures, NovaQuest Capital Management, Pac-Link Ventures, Palo Alto Investors, Shepherd Ventures, Technology Partners, Vivo Ventures |
| Oct 11, 2010 | TriReme Medical | $17.0M Series D | Bio*One Capital | Adams Street Partners, Three Arch Partners |
| Jan 1, 2010 | Revance Therapeutics | $26.0M Series D | — | Vivo Capital, Pac-Link Ventures, Palo Alto Investors, Shepherd Ventures, Technology Partners, Vivo Ventures |
| Dec 1, 2009 | FORMA Therapeutics | $3.0M Series B | Steve Hall | Cubist Pharmaceuticals, Novartis |
| Dec 5, 2008 | Broncus Technologies | $38.0M Other Equity | Ares Life Sciences | Abingworth, Broncus Technologies, Charter Ventures, HBM Healthcare Investments, JAIC America, Menlo Ventures, Pac-Link Ventures, Resuscitated, Saints Capital, Saratoga Ventures, Sightline Ventures |